# EDGAR Filing Document

**Accession Number:** 0001321834
**File Stem:** 0001493152-25-024978
**Filing Date:** 2025-11
**Character Count:** 2669
**Document Hash:** 81f41a5be31a92146cdaed2fc7932ef9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-024978.hdr.sgml**: 20260408

**ACCESSION NUMBER**: 0001493152-25-024978

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251125

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Q/C TECHNOLOGIES, INC.
- **CENTRAL INDEX KEY:** 0001321834
- **STANDARD INDUSTRIAL CLASSIFICATION:** IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1185 AVENUE OF THE AMERICAS
- **STREET 2:** SUITE 249
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036
- **BUSINESS PHONE:** 856-848-8698

**MAIL ADDRESS:**
- **STREET 1:** 1185 AVENUE OF THE AMERICAS
- **STREET 2:** SUITE 249
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TNF Pharmaceuticals, Inc.
- **DATE OF NAME CHANGE:** 20240725

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MyMD Pharmaceuticals, Inc.
- **DATE OF NAME CHANGE:** 20210420

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Akers Biosciences, Inc.
- **DATE OF NAME CHANGE:** 20170413

**Q/C Technologies, Inc.**

1185 Avenue of the Americas

New York, New York 10036

November 25, 2025

**<u>VIA EDGAR</u>**

U.S. Securities and Exchange Commission

Division of Corporation Finance<br> Office of Life Sciences<br> Washington, D.C. 20549

Attention: Jessica Dickerstein

Re: Q/C Technologies, Inc.<br> Registration Statement on Form S-3

Filed on October 3, 2025

File No. 333- 290719 (the "***Registration Statement***")

<u>Request for Acceleration</u>

Ladies and Gentlemen:

Pursuant to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the "***Commission***") under the Securities Act of 1933, as amended, Q/C Technologies, Inc. hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective at 5:00 p.m., Eastern Time, on November 28, 2025, or as soon thereafter as practicable.

Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Alla Digilova, Esq. at (212) 659-4993.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| **Q/C Technologies, Inc.** | **Q/C Technologies, Inc.** |
| By: | /s/ *Joshua Silverman* |
|  | Joshua Silverman |
|  | Executive Chairman |

---

cc: Rick A. Werner, Esq., Haynes and Boone, LLP <br> Alla Digilova, Esq., Haynes and Boone, LLP